Besides, the chemotherapy effect of irinotecan combined with CQ treatment on the tumor in the SW620 SOX2 KD group was better than that in the SW620 control group, suggesting that SOX2 knockdown may increase tumor chemosensitivity in vivo (Supplementary Table S7). Here, SOX2 is linked to neoplasm.